###begin article-title 0
###xml 21 26 <span type="species:ncbi:9606">Human</span>
Structural Models of Human eEF1A1 and eEF1A2 Reveal Two Distinct Surface Clusters of Sequence Variation and Potential Differences in Phosphorylation
###end article-title 0
###begin p 1
Conceived and designed the experiments: DCS PNB CMA. Performed the experiments: DCS. Analyzed the data: DCS PNB HJN DP CMA. Wrote the paper: DCS PNB CMA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 50 55 <span type="species:ncbi:9606">human</span>
Despite sharing 92% sequence identity, paralogous human translation elongation factor 1 alpha-1 (eEF1A1) and elongation factor 1 alpha-2 (eEF1A2) have different but overlapping functional profiles. This may reflect the differential requirements of the cell-types in which they are expressed and is consistent with complex roles for these proteins that extend beyond delivery of tRNA to the ribosome.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 221 226 <span type="species:ncbi:4932">yeast</span>
###xml 760 765 <span type="species:ncbi:4932">yeast</span>
To investigate the structural basis of these functional differences, we created and validated comparative three-dimensional (3-D) models of eEF1A1 and eEF1A2 on the basis of the crystal structure of homologous eEF1A from yeast. The spatial location of amino acid residues that vary between the two proteins was thereby pinpointed, and their surface electrostatic and lipophilic properties were compared. None of the variations amongst buried amino acid residues are judged likely to have a major structural effect on the protein fold, or to affect domain-domain interactions. Nearly all the variant surface-exposed amino acid residues lie on one face of the protein, in two proximal but distinct sub-clusters. The result of previously performed mutagenesis in yeast may be interpreted as confirming the importance of one of these clusters in actin-bundling and filament disorganization. Interestingly, some variant residues lie in close proximity to, and in a few cases show differences in interactions with, residues previously inferred to be directly involved in binding GTP/GDP, eEF1Balpha and aminoacyl-tRNA. Additional sequence-based predictions, in conjunction with the 3-D models, reveal likely differences in phosphorylation sites that could reconcile some of the functional differences between the two proteins.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
The revelation and putative functional assignment of two distinct sub-clusters on the surface of the protein models should enable rational site-directed mutagenesis, including homologous reverse-substitution experiments, to map surface binding patches onto these proteins. The predicted variant-specific phosphorylation sites also provide a basis for experimental verification by mutagenesis. The models provide a structural framework for interpretation of the resulting functional analysis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lund1">[1]</xref>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lee1">[2]</xref>
###xml 436 439 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Chambers1">[3]</xref>
###xml 620 623 620 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Newbery1">[4]</xref>
Translation elongation factor alpha (eEF1A) has a pivotal role in protein synthesis, since it is responsible for delivering aminoacylated tRNAs to the A site of the ribosome. In higher vertebrates, eEF1A is found in two variant forms, encoded by distinct genes [1], and with different expression patterns. The near-ubiquitous form, eEF1A1, is expressed in all tissues throughout development but is absent in adult muscle and heart [2], [3]. The latter tissues express instead eEF1A2 as do certain other cell types including, notably, large motor neurons, islet cells in the pancreas and enteroendocrine cells in the gut [4].
###end p 9
###begin p 10
###xml 39 47 39 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Kahns1">[5]</xref>
###xml 713 716 713 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mansilla1">[6]</xref>
###xml 821 824 806 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-LeSourd1">[7]</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 684 689 <span type="species:ncbi:4932">yeast</span>
Despite sharing 92% sequence identity (Figure 1), paralogous human eEF1A1 and eEF1A2 have different functional profiles. They exhibit similar translation activities, but have different relative affinities for GTP and GDP [5]. eEF1A1 binds GTP more strongly than GDP, whereas the opposite is the case for eEF1A2. The GDP dissociation rate constant is seven-fold higher for eEF1A1 than for eEF1A2, and the GDP/GTP preference ratio is 0.82 for eEF1A1, but 1.50 for eEF1A2. Surprisingly, since this would predict its greater reliance on GTP-exchange factors, eEF1A2 appears to show little or no affinity for the components of the guanine-nucleotide exchange factor (GEF) complex eEF1B in yeast-two-hybrid experiments [6]. eEF1B is made up of three subunits, eEF1Balpha, eEF1BDelta (called eEF1Bbeta in plants) and eEF2Bgamma [7]. The eEF1Balpha and eEF1BDelta subunits possess guanine nucleotide-exchange activity, whereas the eEF2Bgamma subunit is thought to have a more structural role, tethering the complex to the membrane of the endoplasmic reticulum.
###end p 10
###begin title 11
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 55 60 <span type="species:ncbi:4932">yeast</span>
Sequence alignment between human eEF1A1 and eEF1A2 and yeast template.
###end title 11
###begin p 12
###xml 601 605 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Frishman1">[44]</xref>
###xml 1316 1320 1300 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross1">[70]</xref>
###xml 1322 1326 1306 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross2">[71]</xref>
###xml 1392 1396 1376 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Sandbaken1">[77]</xref>
###xml 1460 1464 1444 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Ozturk1">[78]</xref>
###xml 1466 1470 1450 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Ozturk2">[79]</xref>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:4932">yeast</span>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 310 315 <span type="species:ncbi:4932">yeast</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 381 386 <span type="species:ncbi:9606">human</span>
###xml 499 504 <span type="species:ncbi:4932">yeast</span>
###xml 657 662 <span type="species:ncbi:4932">yeast</span>
###xml 886 891 <span type="species:ncbi:9606">human</span>
###xml 988 993 <span type="species:ncbi:4932">yeast</span>
###xml 1116 1121 <span type="species:ncbi:4932">yeast</span>
###xml 1179 1184 <span type="species:ncbi:4932">Yeast</span>
The pair-wise sequence alignment between human eEF1A1 and eEF1A2 is shown: identical residues (yellow background), variant residues (red background). The aligned yeast eEF1A template is shown below with identical residues to the human sequences highlighted (yellow background) and any variant position between yeast and either human sequence shown with a white background. The two human sequences share 92% sequence identity with each other and each show approximately81% sequence identity with the yeast protein. The domain boundaries (domain I: cyan; domain II: green; domain III: pink), and STRIDE [44] secondary structure assignment is traced above the yeast template sequence (arrows = beta-strands; coils = alpha-helices). The amino acid residues involved in domain-domain contacts are indicated with a brown circle (green circle for non-identical equivalent residues between two human variants); those involved in the binding of C-terminal fragment eEF1Balpha are indicated on the yeast sequence with blue rectangles; residues involved in GDP-binding indicated in pink rectangles; and those disordered in the yeast crystal structure are indicated with a dashed rectangle. Yeast mutagenesis data and motifs are highlighted on its sequence: mutations involved in actin bundling/disorganization (red rectangles) [70], [71]; mutations that affect translational fidelity (green rectangles) [77]; mutations that reduce dependence on eEF1B (orange rectangles) [78], [79].
###end p 12
###begin p 13
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Ejiri1">[8]</xref>
###xml 121 124 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Murray1">[9]</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Duttaroy1">[10]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Khacho1">[11]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Chuang1">[12]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Shamovsky1">[13]</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Tatsuka1">[14]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Jeganathan1">[15]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Schlaeger1">[16]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Anand1">[17]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Tomlinson1">[18]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Cao1">[19]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Li1">[20]</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Tomlinson2">[21]</xref>
###xml 1069 1072 1069 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Chambers1">[3]</xref>
###xml 1074 1078 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Newbery2">[22]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lutsep1">[23]</xref>
###xml 564 570 <span type="species:ncbi:9606">humans</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
eEF1A1 has been implicated in additional non-canonical functions (reviewed in [8]), including actin-binding and bundling [9], apoptosis [10], nuclear transport [11], proteasomal-mediated degradation of damaged proteins [12], heat shock [13] and transformation [14]. eEF1A2 has been less extensively studied at the biochemical level, so it is not yet clear how many of these non-canonical functions are shared by this variant. For example, eEF1A2 has been shown to have a role in actin remodeling in cells [15], but has not been shown directly to bind to actin. In humans, eEF1A2 has been shown to have oncogenic properties when inappropriately overexpressed, and has been implicated in ovarian, breast, pancreatic, liver and lung cancer [16], [17], [18], [19], [20], although the mechanism for overexpression remains elusive, and no mutations have been identified in ovarian tumors [21]. Loss of expression of eEF1A2, on the other hand, has been shown in mice to result in motor neuron degeneration reminiscent of motor neuron disease, or amyotrophic lateral sclerosis [3], [22], [23].
###end p 13
###begin p 14
###xml 744 768 744 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 802 827 802 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Nagashima1">[24]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mita1">[25]</xref>
###xml 1204 1207 1204 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Newbery1">[4]</xref>
###xml 730 735 <span type="species:ncbi:4932">yeast</span>
###xml 744 768 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 802 827 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 1258 1264 <span type="species:ncbi:9606">humans</span>
There appears to be a complex interplay between eEF1A and its binding partners that has the net effect of balancing its canonical activity in peptide synthesis with its non-canonical actin-binding and bundling functions. Such a balance may be critical for an as yet little-understood integration of gene expression and cytoskeletal dynamics. In higher eukaryotes, different cell types are likely to have different requirements in terms of both protein synthetic capacity and cytoskeletal regulation. It is possible that competition for binding between aminoacyl-tRNA and actin may tilt the balance between the two functions. The presence of the two variants in mammals creates the potential for greater complexity than is seen in yeast: whilst Saccharomyces cerevisiae has two genes encoding eEF1A and Schizosaccharomyces pombe has three, the encoded proteins are identical within a given species [24], [25]. One hypothesis is that the two mammalian variants eEF1A1 and eEF1A2 differ in the extent to which they participate in peptide synthesis versus actin bundling, and that this lies behind their differential expression in various cell types. For example, motor neurons express eEF1A2 and not eEF1A1 [4]; these cells can reach up to a meter in length in humans, and it is tempting to speculate that their cytoskeletal organization would have different constraints from those of, say, hepatocytes. This hypothesis predicts that there will be differences in binding affinities or specificities for aminoacyl-tRNA and/or actin mediated by differences in the amino acid residues that comprise the respective binding sites.
###end p 14
###begin p 15
###xml 70 78 70 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 454 458 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Rush1">[26]</xref>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Rikova1">[27]</xref>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Molina1">[28]</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Guo1">[29]</xref>
###xml 1046 1050 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Rikova1">[27]</xref>
###xml 1245 1249 1245 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Li1">[20]</xref>
###xml 1260 1266 1260 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EEF1A2</italic>
###xml 1311 1315 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Zhu1">[30]</xref>
###xml 1586 1590 1586 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Molina1">[28]</xref>
###xml 1741 1745 1741 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Rush1">[26]</xref>
###xml 2054 2058 2054 2058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Panasyuk1">[31]</xref>
###xml 2402 2406 2402 2406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lamberti1">[32]</xref>
###xml 2789 2793 2789 2793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Eckhardt1">[33]</xref>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 711 716 <span type="species:ncbi:9606">human</span>
###xml 1128 1136 <span type="species:ncbi:9606">patients</span>
###xml 1625 1630 <span type="species:ncbi:9606">human</span>
From the pair-wise sequence alignment between the two human variants (Figure 1), it is apparent that many of the changes involve substitution of Ser or Thr (total of 11); although no Tyr amino acid residues are lost or gained. This observation leads to a second hypothesis; that differential phosphorylation of the two variants effectively amplifies their chemical differences and promotes functional divergence. It is well known that all four subunits (i.e. one monomeric eEF1A subunit and three eEF1B subunits) of the assembled 'heavy' elongation factor complex are targets for kinases. Large-scale proteomics studies revealed that conserved Tyr residues (Tyr29, Tyr85, Tyr86, Tyr141, Tyr162, Tyr254) in both human eEF1A variants [26], [27], [28], [29] are phosphorylated. In most studies, it is impossible to judge whether peptides variously identified as originating from eEF1A1 or eEF1A2 are actually specific to one variant, as the peptides identified are from regions that are completely conserved between eEF1A1 and eEF1A2. Rikova et al. [27] identify eEF1A2 as a substrate for anaplastic lymphoma kinase in lung cancer patients. This is consistent with expression data as this variant is overexpressed in lung adenocarcinoma cell lines [20] while the EEF1A2 gene is amplified in lung cancer cell lines [30]. Furthermore, we have shown that whilst eEF1A2 is overexpressed in a significant subset of primary lung tumors, eEF1A1 expression remains constant when compared with normal lung tissue (J.Boyd, W.Wallace and C.Abbott, unpublished data). On the other hand, Molina et al. [28], in a study of phosphopeptides in human embryonic kidney cells, identified phosphorylation of, unequivocally, eEF1A1 at Tyr29 and Ser163. Rush et al. [26] identified a number of tyrosine phosphorylation sites in eEF1A from various cell lines, but in each case the phosphorylated peptides are from completely conserved regions and thus could have originated from either variant. Additional confirmation of tyrosine phosphorylation was presented by Panasyuk et al. [31] who proposed that while both variants could be involved in phosphotyrosine-mediated processes, eEF1A2 had greater potential to participate in such signaling pathways. Lamberti et al. confirmed serine and threonine phosphorylation of eEF1A, and suggested other likely Ser and Thr phosphorylation sites based on a bioinformatics study of eEF1A1 [32]. However all of their predicted sites (Ser18, Ser157, Ser316, Ser383, Thr242 and Thr432) are conserved between the two variants and their study did not distinguish between the two variant forms. In agreement with one of the abovementioned phosphorylation predictions, Eckhardt et al. confirmed phosphorylation of Thr432 in eEF1A1 via mass spectrometry and site-directed mutagenesis [33]. Thus the hypothesis that non-conserved Thr and Ser residues of eEF1A1 and eEF1A2 are targets for phosphorylation remains untested. One way to begin investigating this hypothesis is to adopt a structural approach (in conjunction with sequence-based phosphorylation predictors) and to examine whether the residues in question are exposed and accessible to kinases or buried and inaccessible.
###end p 15
###begin p 16
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Schwede1">[34]</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 217 222 <span type="species:ncbi:4932">yeast</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 366 371 <span type="species:ncbi:4932">yeast</span>
To date there have been no published mutagenesis reports specifically aimed at delineating binding sites in the human eEF1A variants but there are mutagenesis data, and several three-dimensional (3-D) structures, for yeast eEF1A. We therefore set out to construct and validate 3-D models of human eEF1A1 and eEF1A2 on the basis of homology with a known structure of yeast eEF1A. Modeling by homology is a well-established technique, and protein models have wide-ranging applications in biomedical research (see [34] for recent review). The plan was to examine the locations in the structure of the non-conserved residues, to assess the extent to which these are exposed (in the case of Ser or Thr) for possible phosphorylation, or occupy putative ligand and protein-binding sites, and thereby to test the aforementioned hypotheses.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Target sequences, template identification and selection
###end title 18
###begin p 19
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Altschul1">[35]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Berman1">[36]</xref>
###xml 367 391 367 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Pittman1">[37]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen2">[39]</xref>
###xml 597 599 581 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 779 786 759 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006315.s001">file S1</xref>
###xml 896 900 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 367 391 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 890 895 <span type="species:ncbi:4932">yeast</span>
The target sequences used were eEF1A1 [residues 1-443 (out of 462); SwissProt Accession No: P68104] and eEF1A2 [residues 1-443 (out of 463); SwissProt Accession No: Q05639]. A BLAST search [35] for each of the target sequences against the Protein Data Bank (PDB) [36] returned six highly similar potential templates [PDB IDs: 1F60, 1G7C, 1IJE, 1IJF, 2B7B, 2B7C] from Saccharomyces cerevisiae[37], [38], [39] with an E-value of 0.0 (sequence identity approximately81%). All these structures were solved in complex with the C-terminal eEF1Balpha fragment and in some cases with GDP, GDPNP, or GDP-Mg2+ bound. Upon superposition, the structural arrangements/orientations for the three domains are almost identical (Calpha RMSD: 0.1 to 0.7 A) among the six structures (Supplementary file S1). The highest resolved structure from this set - the 1.67-A X-ray-derived eEF1A protein structure from yeast [38] (PDB ID: 1F60, chain A) was selected as the template.
###end p 19
###begin title 20
Target-Template alignments
###end title 20
###begin p 21
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Baker1">[40]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Ginalski1">[41]</xref>
###xml 178 186 178 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Thompson1">[42]</xref>
###xml 552 560 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 592 596 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-McGuffin1">[43]</xref>
###xml 684 688 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Frishman1">[44]</xref>
###xml 844 852 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
Optimal template selection, and target-to-template alignment is key to the success of any modeling exercise [40], [41]. The alignment between the targets and template sequences (Figure 1) for modeling purposes, was based on a multiple-sequence alignment among them using the program ClustalX [42]. Because of their high sequence similarity, the alignment was predictably trivial, and no further manual editing was required. The targets eEF1A1 and eEF1A2 share 81% and 80% sequence identity (approximately89% similarity) respectively with the template (Figure 1). Unsurprisingly, PSIPRED v2.5 [43] predicted near-identical secondary structure for both variants (not shown). The STRIDE [44] identified secondary structure for the template when overlaid on the sequence alignment, showed that the two gaps were indeed placed within a loop region (Figure 1).
###end p 21
###begin title 22
Model building and refinement
###end title 22
###begin p 23
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Sali1">[45]</xref>
###xml 205 229 205 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">objective function score</italic>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Bower1">[46]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Canutescu1">[47]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Clark1">[48]</xref>
The two target-template alignments were individually used as inputs for the program Modeller release 8 version 2 [45]. Twenty models were generated and, in each case, the ones with the lowest value of the objective function score were selected as the representative models. Non-identical side-chain residues for each representative model were optimized using the side-chain replacement program, SCWRL version 3 [46], [47]. The models were then protonated under SYBYL version 6.9 (Tripos Associates, St. Louis, MO, USA), and subject to brief energy minimization (20 steps steepest descent, followed by 20 steps conjugate gradients) employing the Tripos forcefield [48] under SYBYL v6.9 to remove clashes and bad geometries.
###end p 23
###begin title 24
Model evaluation
###end title 24
###begin p 25
###xml 65 72 65 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006315.s002">file S2</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Laskowski1">[49]</xref>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vriend1">[50]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vriend2">[51]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Pawlowski1">[52]</xref>
###xml 338 345 338 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006315.s003">file S3</xref>
The models were checked for valid stereochemistry (Supplementary file S2) using PROCHECK version 3.5.4 [49]. The coarse packing quality of the models was assessed using the WHAT IF server () [50], [51], and the models additionally evaluated using the MetaMQAP II server () [52]. The final models are available for download (Supplementary file S3).
###end p 25
###begin title 26
Analysis of model properties
###end title 26
###begin p 27
###xml 176 184 172 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 250 254 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Tina1">[53]</xref>
###xml 766 770 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Shatsky1">[54]</xref>
###xml 888 892 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Fraczkiewicz1">[55]</xref>
###xml 959 963 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Nicholls1">[56]</xref>
###xml 1019 1023 1015 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Heiden1">[57]</xref>
###xml 87 92 <span type="species:ncbi:4932">Yeast</span>
PyMol (; DeLano Scientific, San Carlos, CA, USA) was used for structure visualization. Yeast eEF1A-eEF1Balpha interacting amino acid residues and eEF1A domain-domain contacts (Figure 1) were identified using the Protein Interactions Calculator (PIC) [53]. PIC identifies all hydrophobic interactions within 5 A, main-chain to main-chain, main-chain to side-chain and side-chain to side-chain hydrogen bonds, ionic interactions, aromatic-aromatic interactions, aromatic-sulfur interactions, and cation-pi interactions. Proximity of putative binding site residues with respect to variant amino acid residues was identified by using a 5 A sphere radius from the binding site amino acid residues under PyMol. Structural superpositions were undertaken using MultiProt () [54]. Solvent-accessibility calculations were performed using GETAREA version 1.1 () using a sphere probe radius of 1.4 A [55]. Electrostatic surface representations were generated using GRASP [56] and lipophilic surface renditions created using MOLCAD [57] under SYBYL v6.9.
###end p 27
###begin title 28
Phosphorylation prediction
###end title 28
###begin p 29
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Altschul1">[35]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Blom1">[58]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human eEF1A1 and eEF1A2 amino acid sequences were used to search the translated nucleotide database 'nr/nt' at NCBI using BLAST (tblastn) () [35]. The retrieved orthologues were then used as input to ClustalX for multiple sequence alignment. BOXSHADE was used for shading sequence conservation. Phosphorylation site prediction was performed using the NetPhos version 2 server () [58] and mapped onto the alignment and 3-D model.
###end p 29
###begin title 30
Results and Discussion
###end title 30
###begin title 31
###xml 40 45 <span type="species:ncbi:9606">human</span>
Quality assessment of the 3-D models of human eEF1A1 and eEF1A2
###end title 31
###begin p 32
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Laskowski1">[49]</xref>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Morris1">[59]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vriend1">[50]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vriend2">[51]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Zemla1">[60]</xref>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Pawlowski1">[52]</xref>
###xml 1296 1304 1284 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 1393 1397 1381 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 1524 1528 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Baker1">[40]</xref>
###xml 60 65 <span type="species:ncbi:4932">yeast</span>
###xml 1216 1221 <span type="species:ncbi:4932">yeast</span>
The models of eEF1A1 and eEF1A2 were created based upon the yeast crystal structure of eEF1A and evaluated for stereochemistry, packing quality and expected accuracy. The Ramachandran dihedral statistics [49], [59] for both models were good; eEF1A1: 93.6% most favored, 5.1% additionally allowed, 1.1% generously allowed, 0.3% disallowed; and eEF1A2: 92% most favored, 6.7% additionally allowed, 1.3% generously allowed, 0% disallowed. Additionally, the packing quality [50], [51] for the models attained overall average quality control scores of -0.89 (eEF1A1) and -0.87 (eEF1A2). To place this in context, incorrect models give scores of<-3.0; lower quality models<-2.0; and the average quality of 200 highly refined X-ray structures -0.5 (+or -0.4). The absolute global deviations, expressed as Root Mean Square Deviation (RMSD) and Global Distance Test Total Score (GDT_TS [60]) by MetaMQAP II [52] for the models versus the unknown true structures were sound (eEF1A1: GDT_TS: 80.3, RMSD: 1.9 A and eEF1A2: GDT_TS: 78.5; RMSD: 2.0 A), indicating high quality models. These evaluation statistics are in line with the high sequence identity (approximately81%) and similarity (89%) of the targets to the eukaryotic yeast template, the presence of only two gaps in the target-template alignment (Figure 1), and the high-resolution quality of the determined template crystal structure (1.67 A) [38]. Taken together, the result is that the quality of the models created approaches that of experimentally determined structures [40].
###end p 32
###begin p 33
###xml 57 80 57 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sulfolobus solfataricus</italic>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vitagliano1">[61]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vitagliano2">[62]</xref>
###xml 168 172 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Altschul1">[35]</xref>
###xml 189 193 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Berman1">[36]</xref>
###xml 278 282 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lamberti1">[32]</xref>
###xml 284 288 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Kanibolotsky1">[63]</xref>
###xml 867 871 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vitagliano1">[61]</xref>
###xml 873 877 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vitagliano2">[62]</xref>
###xml 1186 1190 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vitagliano1">[61]</xref>
###xml 1192 1196 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vitagliano2">[62]</xref>
###xml 1395 1399 1375 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Vitagliano2">[62]</xref>
###xml 57 80 <span type="species:ncbi:2287">Sulfolobus solfataricus</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 456 461 <span type="species:ncbi:4932">yeast</span>
###xml 590 595 <span type="species:ncbi:4932">yeast</span>
###xml 704 709 <span type="species:ncbi:4932">yeast</span>
###xml 760 766 <span type="species:ncbi:9606">humans</span>
###xml 1364 1369 <span type="species:ncbi:4932">yeast</span>
###xml 1511 1516 <span type="species:ncbi:4932">yeast</span>
###xml 1590 1595 <span type="species:ncbi:4932">yeast</span>
###xml 1750 1755 <span type="species:ncbi:4932">yeast</span>
Another, albeit less similar template from the archaeon, Sulfolobus solfataricus[61], [62] (approximately53% sequence identity) was also detected from the BLAST search [35] against the PDB [36] and has been used as a template in previous modeling studies for the human variants [32], [63]. This template was not included in our modeling protocol because of its significantly lower sequence similarity, and larger number of gaps (3%) when compared with the yeast template. Moreover, comparison of the secondary structure of this potential template (PDB ID: 1JNY chain A) with the eukaryotic yeast template (PDB ID: 1F60 chain A) reveals differences - for example, two beta-strands at positions 212-223 in yeast that encompass two variant amino acid residues in humans, are absent in archaea; the loop after the third alpha-helix in domain I in the archaeal structures [61], [62] contain eleven residues (Arg66-Phe76) that are disordered - five of these residues are directly involved in eEF1Balpha-binding. This would translate into a dearth of distance restraints for that region for modeling purposes. Additionally, the orientation of two helices and the switch 1 region are different [61], [62]. Finally, while their individual domains overlay reasonably well (Calpha RMSD: 1 to 1.9 A), the relative orientation of domain I with respect to domains II and III in yeast and archaea is different [62]. This may or may not be attributable to the structural rearrangements that accompany eEF1Balpha-binding in the yeast structure, since the domain-domain orientations adopted by a ligand-free yeast eEF1A, is at yet unknown. Nonetheless, given the abovementioned limitations of using the archaeal template, it is prudent to adopt the ligand-bound eEF1A yeast template, singularly, for modeling other eukaryotic targets.
###end p 33
###begin title 34
Domain-domain contacts between the two variants are conserved
###end title 34
###begin p 35
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g002">Figure 2</xref>
Structurally, each model (like the template) consists of three domains, referred to as domain I, domain II and domain III (Figure 2). Domain I (residues 1-to-240) is made up of a Rossmann-fold topology. Domains II (residues 241-to-336) and III (residues 337-to-443) are made up almost entirely from beta-strands; each domain contains two beta-sheets that form a beta-barrel.
###end p 35
###begin title 36
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 16 21 <span type="species:ncbi:9606">human</span>
Yeast template, human eEF1A1 and eEF1A2 models.
###end title 36
###begin p 37
###xml 42 43 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 101 106 <span type="species:ncbi:4932">yeast</span>
Two views rotated by 180degrees about the y-axis depicting cartoon schematic representations of: the yeast eEF1A (yellow)-eEF1Balpha C-terminal fragment (magenta) crystal structure (top panel). The 3-D models of eEF1A1 (blue, middle panel), and eEF1A2 (red, lower panel) show the location of variant side-chains (in stick representation) between the two proteins, colored green. Secondary structure elements have been assigned by default settings in PyMol () and position of domains labeled.
###end p 37
###begin p 38
###xml 122 131 122 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figures 1</xref>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g002">2</xref>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:4932">yeast</span>
###xml 449 454 <span type="species:ncbi:9606">human</span>
###xml 971 976 <span type="species:ncbi:9606">human</span>
The 32 out of 36 variations in amino acid residues between the two human proteins are distributed over all three domains (Figures 1 and 2). The remaining four variations were not modeled because they are present within a disordered region at the C-terminus of the yeast template, and hence it is unknown how they may influence the overall structure or binding-interactions. Only six (out of 32) amino acid residues that are variable between the two human proteins are completely buried in the modeled structures. Two of these are conservative changes (Val87Ile and Leu361Ile) while two others entail substitution of an alanine for another small residue (Ala326Cys and Ala342Ser); the remaining pair of substitutions (Pro161Ala, Ala189Pro), while not so obviously conservative, can readily be accommodated within the protein core as judged from their excellent packing scores. Thus there is nothing to suggest that individual domain structures will differ between the two human variants.
###end p 38
###begin p 39
###xml 109 117 109 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Tina1">[53]</xref>
###xml 443 451 443 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g003">Figure 3</xref>
###xml 1156 1179 1148 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sulfolobus solfataricus</italic>
###xml 1362 1369 1354 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006315.s004">file S4</xref>
###xml 148 153 <span type="species:ncbi:4932">yeast</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 346 351 <span type="species:ncbi:4932">yeast</span>
###xml 734 739 <span type="species:ncbi:9606">human</span>
###xml 834 839 <span type="species:ncbi:4932">yeast</span>
###xml 1091 1096 <span type="species:ncbi:4932">yeast</span>
###xml 1156 1179 <span type="species:ncbi:2287">Sulfolobus solfataricus</span>
###xml 1332 1337 <span type="species:ncbi:4932">yeast</span>
###xml 1537 1542 <span type="species:ncbi:9606">human</span>
###xml 1587 1592 <span type="species:ncbi:9606">human</span>
###xml 1618 1623 <span type="species:ncbi:4932">yeast</span>
A total of 40 out of 42 residues involved in domain-domain contacts amongst the three domains are identical (Figure 1) for the two variants and the yeast template (contacts identified using PIC [53]). The exceptions are Met/Gln335Lys (residue in linker connecting domains II and III) and Asp/Gln417Glu (domain III) in human eEF1A1/eEF1A2, versus yeast eEF1A. The side-chains of these amino acid residues are, however, largely surface-exposed (Figure 3) and they retain their inter-domain H-bonds (from their main-chain oxygen atoms to the side-chains of Cys409 and Lys242, respectively). This excellent conservation of inter-domain interfaces reinforces the inference from the very high quality of the homology-based models that both human variants may adopt the same conformation as observed in the eEF1Balpha-complexed structure of yeast eEF1A. These observations do not shed light on the issue of whether or not domain rearrangements accompany association or disassociation of eEF1B. It is noteworthy that of the 42 residues involved in domain-domain contacts within the eEF1Balpha-bound yeast structure, 17 are not absolutely conserved in the archaeal Sulfolobus solfataricus sequence; likewise, of the 40 residues involved in domain-domain contacts within the unbound archaeal structure, 14 are not absolutely conserved in the yeast sequence (Supplementary file S4). This observation is consistent with the notion that the domain arrangement within the archaeal EF1A structure is not necessarily mirrored in the eEF1B-free forms of human eEF1A, and reinforces our decision to model human eEF1A1 and eEF1A2 on the yeast template.
###end p 39
###begin title 40
Location of variations in amino acids mapped onto surface.
###end title 40
###begin p 41
###xml 53 54 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 595 599 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 630 634 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen2">[39]</xref>
###xml 846 853 836 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 881 885 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross1">[70]</xref>
###xml 887 891 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross2">[71]</xref>
###xml 1034 1038 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Sandbaken1">[77]</xref>
###xml 1263 1267 1253 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Ozturk1">[78]</xref>
###xml 1269 1273 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Ozturk2">[79]</xref>
###xml 1442 1446 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 97 102 <span type="species:ncbi:4932">yeast</span>
###xml 1074 1080 <span type="species:ncbi:9606">humans</span>
###xml 1196 1201 <span type="species:ncbi:4932">yeast</span>
Two equivalent views rotated by 180degrees about the y-axis depicting a surface rendition of the yeast eEF1A crystal structure colored magenta (top panel), and the 3-D models of eEF1A1 colored blue (middle panel) and eEF1A2 colored red (bottom panel). Locations of exposed variant side-chains are mapped onto the surface of the two model proteins (colored green) and labeled on the eEF1A2 model - the variant residue from eEF1A1 is shown on the right-hand side of the label. The two sub-clusters are apparent in this representation. The location of the C-terminal eEF1Balpha-binding site (cyan) [38] and GDP-binding site (yellow) [39] is mapped on the crystal structure. Also highlighted (red) on its surface are: mutations that reduce actin disorganization induced by overexpression of eEF1A, inhibit actin-bundling without altering translation in vivo, and reduce actin-bundling [70], [71]. There are no variants in proximity to those residues implicated on the basis of mutagenesis to be involved in translational fidelity (green) [77]. However, two variant positions in humans - Gln164Glu and Glu168Asp are in close proximity to Arg166 - a conservative mutation for the equivalent residue in yeast (Arg164Lys) was shown to reduce dependence on eEF1B (orange) [78], [79]. Gln164Glu and Glu168Asp, however, both retain their main-chain to main-chain H-bonds with Arg166. Note: for clarity the three proposed aminoacyl-tRNA-binding residues [38] are not shown, since they overlap with already highlighted positions implicated in binding eEF1Balpha (His293 and Arg320) and actin (His294).
###end p 41
###begin title 42
Surface-exposed variant amino acids between the two proteins lie in sub-clusters located on one-side of the protein
###end title 42
###begin p 43
###xml 78 86 78 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g003">Figure 3</xref>
###xml 238 246 234 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g003">Figure 3</xref>
###xml 263 266 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mansilla1">[6]</xref>
###xml 1127 1135 1087 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g004">Figure 4</xref>
###xml 287 292 <span type="species:ncbi:4932">yeast</span>
Mapping the variable residues on the model surfaces (middle and bottom panel, Figure 3) reveals that almost all of them congregate on one face of the molecule - on the opposite face from the C-terminal eEF1Balpha-binding site (top panel, Figure 3) as proposed in [6] on the basis of the yeast crystal structure. These non-conserved residues are located in two distinct sub-clusters on the same face, but separated by a distance of approximately27 A (measured between residues 220 and 417); a circular band of residues lying within domain I (cluster 1, 12 residues, approximately35 A in diameter), and a swathe of residues spread across domains II and III (cluster 2, 14 residues, approximately46x12 A). It seems highly unlikely that such clustering would occur by chance and it is therefore reasonable to infer that the clusters correspond to binding sites for one or more partners. Such an inference is reinforced by multiple- sequence alignments with eukaryotic orthologues in which it is apparent that the residues contributing to these clusters are very highly conserved within their respective eEF1A1 and eEF1A2 families (Figure 4).
###end p 43
###begin title 44
Multiple sequence alignment of eEF1A1 and eEF1A2 orthologues.
###end title 44
###begin p 45
###xml 625 632 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006315.s006">file S6</xref>
ClustalX alignment of eEF1A1 and eEF1A2 sequences from a range of higher order eukaryotes. The results are shaded using BOXSHADE v3.21 (black background = strictly conserved; grey or white background = conservatively substituted or non-conserved). A star-symbol denotes the position of variant Ser and Thr amino acid residues for the two proteins and color-coded according to variant (red = eEF1A1-specific; blue = eEF1A2-specific). NetPhos-predicted phosphorylation sites are indicated by a circle, and experimentally determined phosphorylation sites shown with a 'P' symbol (these are mapped on the models in Supplementary file S6).
###end p 45
###begin p 46
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lamberti1">[32]</xref>
###xml 132 155 132 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sulfolobus solfataricus</italic>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Marco1">[64]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Kanibolotsky1">[63]</xref>
###xml 132 155 <span type="species:ncbi:2287">Sulfolobus solfataricus</span>
###xml 210 215 <span type="species:ncbi:4932">yeast</span>
###xml 308 313 <span type="species:ncbi:4932">yeast</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
Other models for eEF1A1 have been created previously. Lamberti et al. [32] created a homology model of the eEF1A1 variant, based on Sulfolobus solfataricus EF1A, which is probably a less suitable template than yeast eEF1A for several reasons discussed previously. Marco et al. [64] used a model based on the yeast eEF1A template to assess the ability of a potent inhibitor of protein synthesis (didemnin B) to bind human eEF1A1. Neither of these studies extended to human eEF1A2. The only comparative study between eEF1A1 and eEF1A2 to date was performed by Kanibolotsky et al. [63] who reported near-identical modeled structures and speculated on differences in the conformational dynamics of the two variants, but did not highlight the sub-clustering of variable amino acid residues that is a striking feature of the current models. The ligands for these putative binding sites, and any consequent differences in binding specificities of eEF1A1 versus eEF1A2, are a matter of speculation.
###end p 46
###begin title 47
Comparison of electrostatic and lipophilic surface properties
###end title 47
###begin p 48
###xml 277 285 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g003">Figure 3</xref>
###xml 382 390 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g005">Figure 5</xref>
###xml 540 548 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
A closer inspection of surface properties of the modeled structures should help understand how variations in sequence mediate functional differences between eEF1A1 and eEF1A2. Although virtually all the variable residues appear as two sub-clusters on one face of the molecule (Figure 3), this face has similar overall electrostatic and lipophilic characteristics in both molecules (Figure 5). This is consistent with the fact that conservative substitutions of residues account for three-quarters of the variation between the two proteins (Figure 1). Individual conservative changes likely alter functional properties only to a small degree. But the combined effects on molecular recognition of numerous conservative variations congregated in a surface patch could be more dramatic. To this may be added the influence of the few non-conservative variations; for example, the eEF1A2 variant (in comparison with eEF1A1) has replaced neutral polar residues with electronegative residues at positions Glu164 and Glu217, while negative residues are substituted with Ala186 and Gln417 (in cluster 1); the replacement of Phe393 (in eEF1A1) with Ser393 (in eEF1A2) is a particularly notable substitution (in cluster 2).
###end p 48
###begin title 49
Surface properties of the models eEF1A1 and eEF1A2.
###end title 49
###begin p 50
###xml 58 59 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 87 91 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Nicholls1">[56]</xref>
###xml 571 572 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 601 605 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Heiden1">[57]</xref>
(A) Two equivalent views, rotated by 180degrees about the y-axis, of a GRASP-generated [56] surface electrostatic representation of eEF1A1 (upper panel) and eEF1A2 (lower panel). Negative charge is colored red and positive charge colored blue, ranging from -10 kT to +10 kT (k = Boltzmann's constant; T = temperature in Kelvin). Charged residues not present in either protein (non-conservative charged substitutions only) are labeled - the variant equivalent residue is shown on the right-hand side of the label. (B) Two equivalent views, rotated by 180degrees about the y-axis, of a MOLCAD-generated [57] lipophilic surface rendition of the models. Regions of high lipophilicity or hydrophobicity are colored brown and regions of high hydrophilicity are colored blue.
###end p 50
###begin title 51
Analysis of variant amino acid residues with respect to putative protein/ligand binding sites
###end title 51
###begin title 52
(a) eEF1Balpha
###end title 52
###begin p 53
###xml 118 122 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 189 197 181 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g002">Figure 2</xref>
###xml 225 226 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 243 247 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 399 403 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 607 615 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g001">Figure 1</xref>
###xml 1415 1418 1375 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mansilla1">[6]</xref>
###xml 1545 1549 1501 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Pizzuti1">[65]</xref>
###xml 1716 1720 1672 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Chambers2">[66]</xref>
###xml 1866 1870 1822 1826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Chang1">[67]</xref>
###xml 2110 2113 2062 2065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mansilla1">[6]</xref>
###xml 2239 2242 2187 2190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mansilla1">[6]</xref>
###xml 2327 2330 2267 2270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-LeSourd1">[7]</xref>
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
###xml 150 155 <span type="species:ncbi:4932">yeast</span>
###xml 576 581 <span type="species:ncbi:4932">yeast</span>
###xml 591 596 <span type="species:ncbi:9606">human</span>
###xml 661 666 <span type="species:ncbi:4932">yeast</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 813 818 <span type="species:ncbi:9606">human</span>
###xml 1335 1340 <span type="species:ncbi:4932">yeast</span>
###xml 1539 1544 <span type="species:ncbi:9606">human</span>
###xml 1657 1661 <span type="species:ncbi:10090">mice</span>
###xml 1741 1746 <span type="species:ncbi:4932">yeast</span>
###xml 1771 1776 <span type="species:ncbi:10090">mouse</span>
###xml 1798 1803 <span type="species:ncbi:10090">mouse</span>
###xml 1905 1910 <span type="species:ncbi:4932">yeast</span>
###xml 2033 2038 <span type="species:ncbi:4932">yeast</span>
###xml 2444 2449 <span type="species:ncbi:4932">yeast</span>
The yeast eEF1A structure used as a template in the current study was solved in complex with a fragment of eEF1Balpha [38]. Complex formation between yeast eEF1A and eEF1Balpha (fragment) (Figure 2) buries approximately3558 A2 of surface area [38]. The binding site on eEF1A for the eEF1Balpha C-terminal fragment lies mainly on domains I and II, with only a single contact with domain III (Arg428) [38]. A total of 24 out of 26 eEF1A residues that form the binding site for eEF1Balpha, including all eight residues that participate in salt-bridge formation, are invariant in yeast and both human proteins (Figure 1). Two interface residues, Ala76 and Val89 in yeast, are substituted in both human proteins by similarly sized residues, Ser76 and Ile89, respectively. Thus there are no differences between the two human versions of eEF1A in a highly conserved eEF1Balpha-binding site. The only variant (between eEF1A1 and eEF1A2) amino acid residue within proximity of the eEF1Balpha-binding site is Val/Ile320 that lies within 5 A of three interface residues - Asp252, Val253 and Arg322. Val320 (eEF1A1) and Ile320 (eEF1A2) are involved in a hydrophobic interaction with Val253. Hence we may conclude that all three proteins engage with eEF1Balpha C-terminal fragment in the same way and are likely to have similar affinities, despite yeast-two-hybrid studies that failed to demonstrate an eEF1A2-eEF1B interaction [6]. Mansilla et al suggest that there may be brain-specific variants of eEF1Balpha, and although one has been described in human [65], we have shown that this appears to result from expression of a processed pseudogene with no orthologue in mice and is thus unlikely to be of functional significance [66]. However, a further yeast-two-hybrid screen using mouse eEF1A2 as bait for a mouse brain cDNA library also failed to pull out any eEF1B subunits [67]. One explanation for the negative yeast-two-hybrid results is that the N-terminal segment of eEF1Balpha (>100 amino acid residues) - which was not present in the yeast crystal structure - wraps around and contacts the "far-side" of eEF1A1 [6], stabilized by direct contacts at these sites of variation. Moreover, it is known that eEF1A1 also interacts with eEF1BDelta [6]; eEF1BDelta shows sequence similarity to eEF1Balpha, and can also function as a GEF [7]. Clearly, further experiments assessing binding between eEF1A2 and eEF1B subunits using methodologies other than yeast-two-hybrid screens are needed.
###end p 53
###begin title 54
(b) aminoacyl-tRNA
###end title 54
###begin p 55
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen1">[38]</xref>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 311 316 <span type="species:ncbi:9606">human</span>
The placement of aminoacyl-tRNA in the A site of the ribosome is catalyzed by eEF1A. The equivalent residues in the human variants of eEF1A that have been proposed to be part of the aminoacyl-tRNA binding site [38] are Arg322, His295 and His296, which lie within domain II. These residues are conserved in both human variants. As mentioned above, Arg322 is also involved in eEF1Balpha-binding, and hence the fact that Val/Ile320 lies within 5 A of Arg322 might have a bearing on aminoacyl-tRNA binding.
###end p 55
###begin title 56
(c) GDP/GTP
###end title 56
###begin p 57
###xml 108 110 108 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Pittman1">[37]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen2">[39]</xref>
###xml 356 363 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006315.s005">file S5</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-CarrSchmid1">[68]</xref>
###xml 751 755 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Andersen2">[39]</xref>
###xml 29 34 <span type="species:ncbi:4932">yeast</span>
###xml 510 515 <span type="species:ncbi:4932">yeast</span>
###xml 817 822 <span type="species:ncbi:9606">human</span>
###xml 1109 1114 <span type="species:ncbi:4932">yeast</span>
###xml 1264 1269 <span type="species:ncbi:4932">yeast</span>
###xml 1335 1340 <span type="species:ncbi:4932">yeast</span>
The co-crystal structures of yeast eEF1A bound to GDP, GDPnP (a non-hydrolyzable analogue of GTP) and GDP-Mg2+[37], [39] provided a detailed picture of the guanine-binding pocket. This work revealed the critical importance of Gly19, Lys20, Ser21, Thr22, Asn153, Lys154 and Asp156 (all in domain I) within the binding sites for these ligands (Supplementary file S5). These observations were in agreement with previously performed mutagenesis studies [68] - for example, the Asn153Thr and Asp156Asn mutations of yeast eEF1A resulted in dramatic reduction in translational fidelity. Interestingly, between the unbound eEF1A-eEF1Balpha and the eEF1A-eEF1Balpha-GDP/GDPnP bound conformations, Asp156 is reoriented so as to form H-bonds to the guanine-base [39]. This guanine-binding pocket is absolutely conserved in both human variants and such an observation must be reconciled with their differences in GDP/GTP preference ratios. In this respect it may be relevant that some variant residues - Gln164Glu, Asn197His and Ala206Pro (eEF1A1 versus eEF1A2 - equivalent to Glu162, Asn195 and Thr204, respectively, in yeast) lie close to the guanine-binding pocket. Of particular note is residue 197 that lies immediately adjacent to Asp156; in the eEF1A1 model, as in the yeast eEF1A structure, there is a H-bond between the Asn197 (Asn195 in yeast) and Asp156 side-chains. Such an H-bond cannot exist in eEF1A2 (in which position 197 is occupied by a His), although it could be replaced by an ionic interaction. Such a situation in which a key GDP/GTP contact residue is perturbed could lie behind the differential guanine binding of the two variants.
###end p 57
###begin title 58
(d) Actin
###end title 58
###begin p 59
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Liu1">[69]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross1">[70]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross2">[71]</xref>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross1">[70]</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross2">[71]</xref>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Gross2">[71]</xref>
###xml 116 121 <span type="species:ncbi:4932">yeast</span>
###xml 288 293 <span type="species:ncbi:4932">yeast</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 565 570 <span type="species:ncbi:4932">yeast</span>
###xml 745 750 <span type="species:ncbi:4932">yeast</span>
###xml 889 894 <span type="species:ncbi:4932">yeast</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1049 1054 <span type="species:ncbi:4932">yeast</span>
###xml 1148 1154 <span type="species:ncbi:9606">humans</span>
###xml 1286 1291 <span type="species:ncbi:4932">yeast</span>
###xml 1371 1376 <span type="species:ncbi:9606">human</span>
###xml 1538 1543 <span type="species:ncbi:9606">human</span>
Actin and aminoacyl-tRNA-binding to eEF1A are mutually exclusive [69]. Previously undertaken mutagenesis studies in yeast [70], [71] identified up to eight residues in eEF1A clustered within domains II and III, which (i) reduce actin disorganization induced by overexpression of eEF1A in yeast, (ii) inhibit actin-bundling without altering translation in vivo, and/or (iii) reduce actin-bundling. Two such residues implicated in actin-related functions correspond to variant residues for the human proteins within sub-cluster 2. Indeed, a site-directed mutation in yeast eEF1A, Asn329Ser, fortuitously corresponds to changing eEF1A1 Asn331 to its eEF1A2 equivalent, Ser331. This is one of two mutations (along with Asn329Asp) that were shown in yeast to reduce actin-bundling or actin disorganization that is induced by overexpression of eEF1A [70], [71]. Additionally, another equivalent yeast eEF1A residue that is implicated in actin-related functions is variable (Met335Gln) between the two human proteins in sub-cluster 2. Also of note is that yeast eEF1A Phe308 is implicated in actin-related functions by mutagenesis [71]; the equivalent in humans (Phe310) contacts Ala326 in eEF1A1 (hydrophobic interaction) or Cys326 in eEF1A2 (aromatic-sulfur interaction). In a similar vein, yeast eEF1A Tyr355 is critical for actin-related functions and the side-chain of its human equivalent (Tyr357) is adjacent to the side-chain of either Ala358 in eEF1A1 or Ser358 in eEF1A2. So these differences (Ala326Cys and Ala358Ser) between the two human variants could have ramifications for adjacent sites critical for actin-related functionality. Previously performed mutagenesis studies thus serendipitously confirm the importance of one of the two clusters/binding patches in actin-related functions; this suggests that the two variants have different actin-binding and bundling properties consistent with our original hypothesis. Moreover, this study provides a direction for further mutagenesis experiments that should target sub-cluster 2 as a means of understanding the role of the actin-eEF1A interaction.
###end p 59
###begin title 60
Homologous (reverse) substitution mutagenesis can reconcile functional disparities
###end title 60
###begin p 61
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Krych1">[72]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Krych2">[73]</xref>
Our observation of two clusters of variant residues on the surface of eEF1A1/2 creates the possibility of conducting rational homologous (reverse) substitution mutagenesis. This is a well-established approach to delineating precisely which amino acid residues are responsible for specific functional differences between highly similar proteins e.g. [72], [73]. Thus, the involvement of those residues predicted to lie within or close to the actin-binding cluster Asn/Ser331, Met/Gln335, Ala/Cys326 and Ala/Ser358 should be investigated by this route. Similarly, eEF1A1 mutations Asn197His (potentially important for GTP/GDP-binding), and Val320Ile (may be involved in aminoacyl-tRNA-binding and eEF1Balpha-binding) should be probed.
###end p 61
###begin title 62
Using the modeled structures to infer differences in potential sites of phosphorylation
###end title 62
###begin p 63
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g004">Figure 4</xref>
###xml 1003 1011 1003 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006315-g003">Figure 3</xref>
###xml 1027 1034 1027 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006315.s006">file S6</xref>
###xml 1266 1270 1266 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Iakoucheva1">[74]</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 407 412 <span type="species:ncbi:4932">yeast</span>
###xml 1153 1158 <span type="species:ncbi:4932">yeast</span>
Many of the amino acid differences between the two human variants involve substitution of Ser or Thr residues (total of 11) and it is interesting to observe the presence and almost strict conservation of variant-specific Ser and Thr positions among orthologues in higher eukaryotes (Figure 4). Four out of the eight experimentally confirmed phosphorylation sites for the human variants are not conserved in yeast. A sequence-based NetPhos phosphorylation analysis of the two variants predicts (>0.5 probability score) five of these eleven sites to be both variant-specific and potential phosphorylatable. These include Thr217 and Thr227 in eEF1A1; and Ser358, Ser393 and Ser445 in eEF1A2. The last two residues in eEF1A2 have >0.95 probability scores [Ser393 (0.99) and Ser445 (0.96)]. When a kinase encounters a potential substrate for phosphorylation, it recognises the surface of the protein. From the 3-D models, Thr217, Thr227 (eEF1A1), Ser358 and Ser393 (eEF1A2) all expose their hydroxyl-groups (Figure 3; Supplementary file S6). Ser445 (eEF1A2) on the other hand, lies in the C-terminal region that was not modeled; the equivalent region in the yeast crystal structure was disordered. It is known that phosphorylation frequently occurs in disordered regions [74], hence this site too forms another prime candidate for phosphorylation.
###end p 63
###begin p 64
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Kassenbrock1">[75]</xref>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mayo1">[76]</xref>
Although overexpression of eEF1A2 has been implicated in a range of different tumor types, no such role for eEF1A1 has yet been established. It is tempting to speculate that any difference in oncogenic potential between the two variants lies in the different phosphorylation potential of eEF1A1 and eEF1A2. It will thus be important to confirm phosphorylation of the two most likely eEF1A2 sites - Ser393 and Ser445 - using, for example, mass spectrometry. Furthermore, it would be useful to create phosphorylation mimics, through mutagenesis of Ser or Thr to Asp or Glu [75], [76], or to a non-phosphorylatable amino acid residue such as the eEF1A1-equivalent. If Ser393 and Ser445 are indeed phosphorylated, it would be interesting to raise antibodies to the phosphorylated forms of eEF1A2 and use these to establish whether any differences can be seen between eEF1A2 expressed in tumor compared to normal tissue. Such studies would not only yield biological insights but could also provide useful diagnostic reagents.
###end p 64
###begin title 65
Conclusions
###end title 65
###begin p 66
We set out to use homology modeling to address two hypotheses: first, amino acid differences between the two variants dictate differences in relative binding affinities or specificities for aminoacyl-tRNA and/or actin, reflecting differential roles in various cell types; second, differential phosphorylation of the two variants effectively amplifies their chemical differences and promotes functional divergence. The 3-D models reveal two distinct sub-clusters of sequence variation on one face of the proteins. We observed that variable amino acid residues within one of these clusters overlapped with residues implicated in actin-bundling and disorganization. Some other variable residues participate in interactions with, or lie in close proximity to, amino acid residues directly involved in binding GTP/GDP, eEF1Balpha and aminoacyl-tRNA. These findings are in predictive agreement with our first hypothesis and identify, high-priority targets for rational site-directed mutagenesis including homologous reverse substitution experiments. In addition the models, in support of our second hypothesis, suggest possible differences of phosphorylation and hence future experiments to investigate differences in phosphorylation between the variants.
###end p 66
###begin title 67
Supporting Information
###end title 67
###begin p 68
###xml 136 139 136 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Newbery1">[4]</xref>
###xml 290 293 286 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Kahns1">[5]</xref>
###xml 295 298 291 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Mansilla1">[6]</xref>
###xml 578 581 574 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-LeSourd1">[7]</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 74 79 <span type="species:ncbi:4932">yeast</span>
###xml 524 529 <span type="species:ncbi:4932">yeast</span>
Yeast crystal structure comparison. (A) Table depicting the six different yeast eEF1A crystal structures in the Protein Data Bank (PDB) [4], resolution, PDB chains and solved residue lengths, along with each of their corresponding interacting eEF1Balpha proteins and ligands. (B) MultiProt [5], [6] structural superposition of all six eEF1A crystal structures highlights the structural conservation among them. Each structure color-coded differently. (C) Table depicting the pair-wise structural comparisons for all vs. all yeast crystal structures. The Combinatorial Extension [7] calculated Calpha root mean square deviation (RMSD) is shown in Angstroms along with the structural alignment length between the two proteins. The closeness of the structures is evident in this table.
###end p 68
###begin p 69
(0.13 MB PDF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 498 501 498 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lund1">[1]</xref>
###xml 503 506 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lee1">[2]</xref>
###xml 44 49 <span type="species:ncbi:9606">human</span>
Ramachandran evaluation plots for models of human eEF1A1 and eEF1A2. Top: Ramachandran plot scores for eEF1A1: most favored regions: 93.6%; additional allowed regions: 5.1%; generously allowed regions: 1.1%; disallowed regions: 0.3%. Bottom: Ramachandran plot scores for eEF1A2: most favored regions: 92%; additional allowed regions: 6.7%; generously allowed regions: 1.3%; disallowed regions: 0%. Ideally, one would hope to have>90% residues in the "most favored" regions of the Ramachandran plot [1], [2].
###end p 71
###begin p 72
(0.09 MB PDF)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
3-D model co-ordinates of human eEF1A1 and eEF1A2. Note: co-ordinates for both models (human eEF1A1 and human eEF1A2) are provided in one PDB file.
###end p 74
###begin p 75
(1.13 MB TXT)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 42 65 42 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sulfolobus solfataricus</italic>
###xml 78 102 78 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 42 65 <span type="species:ncbi:2287">Sulfolobus solfataricus</span>
###xml 71 76 <span type="species:ncbi:4932">yeast</span>
###xml 78 102 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 159 164 <span type="species:ncbi:4932">yeast</span>
###xml 211 216 <span type="species:ncbi:4932">yeast</span>
###xml 305 310 <span type="species:ncbi:4932">yeast</span>
###xml 795 800 <span type="species:ncbi:4932">yeast</span>
###xml 1035 1040 <span type="species:ncbi:4932">yeast</span>
Sequence alignment between archaeal EF1A (Sulfolobus solfataricus) and yeast (Saccharomyces cerevisiae) eEF1A. Pair-wise sequence alignment between eEF1A from yeast vs. EF1A from archaea. From the structures of yeast and archaea, residues involved in domain-domain contacts are depicted as follows: *  =  yeast amino acid residue involved in domain-domain contact, when bound to eEF1Balpha; &  =  archaea amino acid residue involved in domain-domain contact, free of eEF1Balpha; underlined residues  =  not present in the crystal structures. Identical positions in the alignment are shown with a yellow background; variable positions involved in a domain-domain contact are highlighted with a red background. A total of 42 residues are involved in domain-domain contacts in the eEF1Balpha-bound yeast structure, 17 are non-identical at the equivalent position in the archaeal sequence, and conversely, there are 40 residues involved in domain-domain contacts within the unbound archaeal structure, 14 of which are non-identical in the yeast sequence.
###end p 77
###begin p 78
(0.08 MB PDF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 26 31 <span type="species:ncbi:4932">yeast</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 126 131 <span type="species:ncbi:4932">yeast</span>
###xml 161 166 <span type="species:ncbi:4932">yeast</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 449 454 <span type="species:ncbi:4932">yeast</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 604 609 <span type="species:ncbi:9606">human</span>
###xml 642 647 <span type="species:ncbi:4932">yeast</span>
###xml 661 666 <span type="species:ncbi:9606">human</span>
Guanine-binding pocket in yeast and human variants. Close-up equivalent views of residues involved in binding of GTP/GDP: the yeast template (top left); all six yeast eEF1A structures superposed (top right) and colored differently (see their corresponding PDB IDs below); human eEF1A1 (bottom left); and human eEF1A2 (bottom right). Labeled residues include: Gly19, Lys20, Ser21, Thr22, Asn153, Lys154, Asp156 [GTP/GDP-binding residues] and Asn195 (yeast), Asn/His197 (human eEF1A1/eEF1A2) that show presence of H-bond (indicated by a yellow dashed line and distance in Angstroms) with Asp156, absent in human eEF1A2. Atomic color scheme for yeast template and human variants: nitrogen: blue; oxygen: red; carbon: yellow (note: for clarity hydrogen atoms not shown).
###end p 80
###begin p 81
(0.15 MB PDF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 774 777 774 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006315-Lund1">[1]</xref>
###xml 550 555 <span type="species:ncbi:9606">human</span>
Location of known and variable potential phosphorylatable residues on eEF1A1 and eEF1A2 models. Cartoon schematic representation of the 3-D models of eEF1A1 and eEF1A2 depicting the location of the known (orange) and potential (green) phospho-Ser, -Thr and -Tyr residues (side-chain shown in stick representation without hydrogen atoms, for clarity). Potentially phosphorylated Ser445 in eEF1A2 is located in a disordered region, and is hence not seen in the figure. Note: all experimentally confirmed phosphorylation sites are conserved between the human variants, and have not been unambiguously determined specifically to each or both variants. For purposes of the figure, phosphorylated residues are depicted on the models as reported in the PhosphoSitePlus database () [1]: for eEF1A1 (Tyr29, Tyr85, Tyr86, Tyr141, Tyr162, Ser163, and Thr432); and for eEF1A2 (Tyr29, Tyr141, and Tyr254).
###end p 83
###begin p 84
(0.54 MB PDF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
###xml 14 19 <span type="species:ncbi:9606">human</span>
Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3.
###end article-title 87
###begin article-title 88
Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1 alpha gene family.
###end article-title 88
###begin article-title 89
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
The lethal mutation of the mouse wasted (wst) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1alpha, encoded by the Eef1a2 gene.
###end article-title 89
###begin article-title 90
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Translation elongation factor eEF1A2 is essential for post-weaning survival in mice.
###end article-title 90
###begin article-title 91
###xml 41 47 <span type="species:ncbi:9986">rabbit</span>
The elongation factor 1 A-2 isoform from rabbit: cloning of the cDNA and characterization of the protein.
###end article-title 91
###begin article-title 92
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:4932">yeast</span>
Mapping the human translation elongation factor eEF1H complex using the yeast two-hybrid system.
###end article-title 92
###begin article-title 93
eEF1B: At the dawn of the 21st century.
###end article-title 93
###begin article-title 94
Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization.
###end article-title 94
###begin article-title 95
Bundling of actin filaments by elongation factor 1 alpha inhibits polymerization at filament ends.
###end article-title 95
###begin article-title 96
Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha.
###end article-title 96
###begin article-title 97
eEF1A is a novel component of the mammalian nuclear protein export machinery.
###end article-title 97
###begin article-title 98
Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A.
###end article-title 98
###begin article-title 99
RNA-mediated response to heat shock in mammalian cells.
###end article-title 99
###begin article-title 100
Elongation factor-1 alpha gene determines susceptibility to transformation.
###end article-title 100
###begin article-title 101
Eukaryotic elongation factor 1A2 cooperates with phosphatidylinositol-4 kinase III beta to stimulate production of filopodia through increased phosphatidylinositol-4,5 bisphosphate generation.
###end article-title 101
###begin article-title 102
###xml 43 48 <span type="species:ncbi:9606">human</span>
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
###end article-title 102
###begin article-title 103
Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer.
###end article-title 103
###begin article-title 104
Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours.
###end article-title 104
###begin article-title 105
Regulation and functional role of eEF1A2 in pancreatic carcinoma.
###end article-title 105
###begin article-title 106
Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
###end article-title 106
###begin article-title 107
Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus.
###end article-title 107
###begin article-title 108
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Progressive loss of motor neuron function in wasted mice: effects of a spontaneous null mutation in the gene for the eEF1 A2 translation factor.
###end article-title 108
###begin article-title 109
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Ultrastructural, morphometric, and immunocytochemical study of anterior horn cells in mice with "wasted" mutation.
###end article-title 109
###begin article-title 110
###xml 100 124 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Structure of the two genes coding for polypeptide chain elongation factor 1 alpha (EF-1 alpha) from Saccharomyces cerevisiae.
###end article-title 110
###begin article-title 111
###xml 25 50 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Comprehensive cloning of Schizosaccharomyces pombe genes encoding translation elongation factors.
###end article-title 111
###begin article-title 112
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
###end article-title 112
###begin article-title 113
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.
###end article-title 113
###begin article-title 114
Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.
###end article-title 114
###begin article-title 115
Signaling networks assembled by oncogenic EGFR and c-Met.
###end article-title 115
###begin article-title 116
High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines.
###end article-title 116
###begin article-title 117
A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling molecules.
###end article-title 117
###begin article-title 118
###xml 52 57 <span type="species:ncbi:9606">human</span>
C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A.
###end article-title 118
###begin article-title 119
Male germ cell expression of the PAS domain kinase PASKIN and its novel target eukaryotic translation elongation factor eEF1A1.
###end article-title 119
###begin article-title 120
Outcome of a workshop on applications of protein models in biomedical research.
###end article-title 120
###begin article-title 121
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
###end article-title 121
###begin article-title 122
The Protein Data Bank.
###end article-title 122
###begin article-title 123
Mg2+ and a key lysine modulate exchange activity of eukaryotic translation elongation factor 1B alpha.
###end article-title 123
###begin article-title 124
###xml 74 79 <span type="species:ncbi:4932">yeast</span>
Structural basis for nucleotide exchange and competition with tRNA in the yeast elongation factor complex eEF1A:eEF1Balpha.
###end article-title 124
###begin article-title 125
Crystal structures of nucleotide exchange intermediates in the eEF1A-eEF1Balpha complex.
###end article-title 125
###begin article-title 126
Protein structure prediction and structural genomics.
###end article-title 126
###begin article-title 127
Comparative modeling for protein structure prediction.
###end article-title 127
###begin article-title 128
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
###end article-title 128
###begin article-title 129
The PSIPRED protein structure prediction server.
###end article-title 129
###begin article-title 130
Knowledge-based protein secondary structure assignment.
###end article-title 130
###begin article-title 131
Comparative protein modelling by satisfaction of spatial restraints.
###end article-title 131
###begin article-title 132
Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool.
###end article-title 132
###begin article-title 133
A graph-theory algorithm for rapid protein side-chain prediction.
###end article-title 133
###begin article-title 134
Validation of the General-Purpose Tripos 5.2 Force-Field.
###end article-title 134
###begin article-title 135
Procheck - a Program to Check the Stereochemical Quality of Protein Structures.
###end article-title 135
###begin article-title 136
What If - a Molecular Modeling and Drug Design Program.
###end article-title 136
###begin article-title 137
Quality-Control of Protein Models - Directional Atomic Contact Analysis.
###end article-title 137
###begin article-title 138
MetaMQAP: a meta-server for the quality assessment of protein models.
###end article-title 138
###begin article-title 139
PIC: Protein Interactions Calculator.
###end article-title 139
###begin article-title 140
A method for simultaneous alignment of multiple protein structures.
###end article-title 140
###begin article-title 141
Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules.
###end article-title 141
###begin article-title 142
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
###end article-title 142
###begin article-title 143
A new approach to analysis and display of local lipophilicity/hydrophilicity mapped on molecular surfaces.
###end article-title 143
###begin article-title 144
Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.
###end article-title 144
###begin article-title 145
Stereochemical quality of protein structure coordinates.
###end article-title 145
###begin article-title 146
Processing and evaluation of predictions in CASP4.
###end article-title 146
###begin article-title 147
###xml 25 48 <span type="species:ncbi:2287">Sulfolobus solfataricus</span>
The crystal structure of Sulfolobus solfataricus elongation factor 1alpha in complex with GDP reveals novel features in nucleotide binding and exchange.
###end article-title 147
###begin article-title 148
###xml 25 48 <span type="species:ncbi:2287">Sulfolobus solfataricus</span>
The crystal structure of Sulfolobus solfataricus elongation factor 1alpha in complex with magnesium and GDP.
###end article-title 148
###begin article-title 149
###xml 58 63 <span type="species:ncbi:9606">human</span>
Multiple molecular dynamics simulation of the isoforms of human translation elongation factor 1A reveals reversible fluctuations between "open" and "closed" conformations and suggests specific for eEF1A1 affinity for Ca2+-calmodulin.
###end article-title 149
###begin article-title 150
###xml 49 54 <span type="species:ncbi:9606">human</span>
Structural basis for the binding of didemnins to human elongation factor eEF1A and rationale for the potent antitumor activity of these marine natural products.
###end article-title 150
###begin article-title 151
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human elongation factor EF-1 beta: cloning and characterization of the EF1 beta 5a gene and assignment of EF-1 beta isoforms to chromosomes 2,5,15 and X.
###end article-title 151
###begin article-title 152
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Comparative genomic analysis of genes encoding translation elongation factor 1B(alpha) in human and mouse shows EEF1B1 to be a recent retrotransposition event.
###end article-title 152
###begin article-title 153
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse translation elongation factor eEF1A-2 interacts with Prdx-I to protect cells against apoptotic death induced by oxidative stress.
###end article-title 153
###begin article-title 154
Mutations in a GTP-binding motif of eukaryotic elongation factor 1A reduce both translational fidelity and the requirement for nucleotide exchange.
###end article-title 154
###begin article-title 155
F-actin sequesters elongation factor 1alpha from interaction with aminoacyl-tRNA in a pH-dependent reaction.
###end article-title 155
###begin article-title 156
Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology.
###end article-title 156
###begin article-title 157
Improper organization of the actin cytoskeleton affects protein synthesis at initiation.
###end article-title 157
###begin article-title 158
Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.
###end article-title 158
###begin article-title 159
Structure-function analysis of the active sites of complement receptor type 1.
###end article-title 159
###begin article-title 160
The importance of intrinsic disorder for protein phosphorylation.
###end article-title 160
###begin article-title 161
Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
###end article-title 161
###begin article-title 162
###xml 19 24 <span type="species:ncbi:9606">human</span>
Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
###end article-title 162
###begin article-title 163
###xml 115 139 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Mutations in elongation factor EF-1 alpha affect the frequency of frameshifting and amino acid misincorporation in Saccharomyces cerevisiae.
###end article-title 163
###begin article-title 164
Guanine nucleotide exchange factor independence of the G-protein eEF1A through novel mutant forms and biochemical properties.
###end article-title 164
###begin article-title 165
###xml 35 59 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Unique classes of mutations in the Saccharomyces cerevisiae G-protein translation elongation factor 1A suppress the requirement for guanine nucleotide exchange.
###end article-title 165
###begin p 166
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 166
###begin p 167
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was funded in part by a Scottish Funding Council Strategic Research Development Grant fund (support for DCS) and a grant from the Wellcome Trust to CMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 167

